Cargando…

Heterologous vaccine immunogenicity, efficacy, and immune correlates of protection of a modified-live virus porcine reproductive and respiratory syndrome virus vaccine

Although porcine reproductive and respiratory syndrome virus (PRRSV) vaccines have been available in North America for almost 30 years, many vaccines face a significant hurdle: they must provide cross-protection against the highly diverse PRRSV strains. This cross-protection, or heterologous vaccine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Proctor, Jessica, Wolf, Iman, Brodsky, David, Cortes, Lizette M., Frias-De-Diego, Alba, Almond, Glen W., Crisci, Elisa, Negrão Watanabe, Tatiane Terumi, Hammer, James M., Käser, Tobias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537733/ https://www.ncbi.nlm.nih.gov/pubmed/36212883 http://dx.doi.org/10.3389/fmicb.2022.977796

Ejemplares similares

The Local and Systemic Humoral Immune Response Against Homologous and Heterologous Strains of the Type 2 Porcine Reproductive and Respiratory Syndrome Virus
por: Kick, Andrew R., et al.
Publicado: (2021)

Testable Candidate Immune Correlates of Protection for Porcine Reproductive and Respiratory Syndrome Virus Vaccination
por: Kick, Andrew R., et al.
Publicado: (2023)

The T-Cell Response to Type 2 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV)
por: Kick, Andrew R., et al.
Publicado: (2019)

Maternal Autogenous Inactivated Virus Vaccination Boosts Immunity to PRRSV in Piglets
por: Kick, Andrew R., et al.
Publicado: (2021)

A Heterologous Prime/Boost Vaccination Strategy Enhances the Immunogenicity of Therapeutic Vaccines for Hepatitis C Virus
por: Fournillier, Anne, et al.
Publicado: (2013)

Systems Immunology Analyses Following Porcine Respiratory and Reproductive Syndrome Virus Infection and Vaccination
por: Bocard, Loïc Vivien, et al.
Publicado: (2021)

Immunogenicity and reactogenicity of heterologous COVID-19 vaccination in pregnant women
por: Chayachinda, Chenchit, et al.
Publicado: (2023)

Comparison of the efficacy of autogenous inactivated Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) vaccines with that of commercial vaccines against homologous and heterologous challenges
por: Geldhof, Marc F, et al.
Publicado: (2012)

Safety and immunogenicity of a heterologous booster with an RBD virus-like particle vaccine following two- or three-dose inactivated COVID-19 vaccine
por: Yong, Xiaolan, et al.
Publicado: (2023)

Safety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and Senegal
por: Venkatraman, Navin, et al.
Publicado: (2019)

Comparative analysis of routes of immunization of a live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in a heterologous virus challenge study
por: Ouyang, Kang, et al.
Publicado: (2016)

Reactogenicity and immunogenicity of heterologous prime-boost immunization with COVID-19 vaccine
por: Nguyen, Thuy Trang, et al.
Publicado: (2022)

Immunogenicity of a heterologous COVID-19 vaccine after failed vaccination in a lymphoma patient
por: Hill, Joshua A., et al.
Publicado: (2021)

Efficacy of infectious bronchitis virus vaccines against heterologous challenge
por: MUNEER, M.A., et al.
Publicado: (1988)

Virus-Induced T Cell-Mediated Heterologous Immunity and Vaccine Development
por: Balz, Kathrin, et al.
Publicado: (2020)

Heterologous prime-boost vaccination with DNA and MVA vaccines, expressing HIV-1 subtype C mosaic Gag virus-like particles, is highly immunogenic in mice
por: Chapman, Ros, et al.
Publicado: (2017)

Immunogenicity of a Heterologous Prime-Boost COVID-19 Vaccination with mRNA and Inactivated Virus Vaccines Compared with Homologous Vaccination Strategy against SARS-CoV-2 Variants
por: Zhang, Ruiqi, et al.
Publicado: (2022)

Assessing the immunogenicity and toxicity of the AFPL1-conjugate nicotine vaccine using heterologous and homologous vaccination routes
por: Fraleigh, Nya L., et al.
Publicado: (2019)

Heterologous virus peptide immunogen production: recombinant vaccine production in L-cell, Chinese hamster ovary, C127 cell culture
Publicado: (1989)

Immunogenicity and safety of virus-like particle of the porcine encephalomyocarditis virus in pig
por: Jeoung, Hye-Young, et al.
Publicado: (2011)

Macaques vaccinated with live-attenuated SIV control replication of heterologous virus
por: Reynolds, Matthew R., et al.
Publicado: (2008)

A Novel Neuraminidase Virus-Like Particle Vaccine Offers Protection Against Heterologous H3N2 Influenza Virus Infection in the Porcine Model
por: Pliasas, Vasilis C., et al.
Publicado: (2022)

Various Adjuvants Effect on Immunogenicity of Puumala Virus Vaccine
por: Kurashova, Svetlana S., et al.
Publicado: (2020)

Virus-Like Particles as an Immunogenic Platform for Cancer Vaccines
por: Caldeira, Jerri C., et al.
Publicado: (2020)

Immunogenicity of poxvirus-based vaccines against Nipah virus
por: Medina-Magües, Emily S., et al.
Publicado: (2023)

Virus-like particle-based vaccines for animal viral infections
por: Crisci, Elisa, et al.
Publicado: (2013)

Immunogenicity of heterologous inactivated and adenoviral-vectored COVID-19 vaccine: Real-world data
por: Wanlapakorn, Nasamon, et al.
Publicado: (2022)

Construction and Immunogenicity of DNA Vaccines Encoding Fusion Protein of Porcine IFN-λ1 and GP5 Gene of Porcine Reproductive and Respiratory Syndrome Virus
por: Du, Luping, et al.
Publicado: (2013)

Virus-like particles: The new frontier of vaccines for animal viral infections
por: Crisci, Elisa, et al.
Publicado: (2012)

Recombinant measles AIK-C vaccine strain expressing heterologous virus antigens
por: Nakayama, Tetsuo, et al.
Publicado: (2016)

Heterologous viral protein interactions within licensed seasonal influenza virus vaccines
por: Koroleva, Marina, et al.
Publicado: (2020)

Comparison of Host Immune Responses to Homologous and Heterologous Type II Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Challenge in Vaccinated and Unvaccinated Pigs
por: Li, X., et al.
Publicado: (2014)

Immunogenicity and efficacy of Schmallenberg virus envelope glycoprotein subunit vaccines
por: Endalew, Abaineh D., et al.
Publicado: (2019)

Construction and immunogenicity of an mRNA vaccine against chikungunya virus
por: Liu, Jingjing, et al.
Publicado: (2023)

Immunogenicity and Efficacy of Vaccination in People Living with Human Immunodeficiency Virus
por: Tortellini, Eeva, et al.
Publicado: (2023)

Retracted: Construction and Immunogenicity of DNA Vaccines Encoding Fusion Protein of Porcine IFN-λ1 and GP5 Gene of Porcine Reproductive and Respiratory Syndrome Virus
por: International, BioMed Research
Publicado: (2022)

Differential immunogenicity of homologous versus heterologous boost in Ad26.COV2.S vaccine recipients
por: Khoo, Nicholas Kim Huat, et al.
Publicado: (2022)

Immunogenicity and Efficacy Evaluation of Subunit Astrovirus Vaccines
por: Bidokhti, Mehdi R.M., et al.
Publicado: (2019)

Antibiotic Therapy Does Not Alter the Humoral Response to Vaccination for Porcine Circovirus 2 in Weaned Pigs
por: Fogle, Jonathan E., et al.
Publicado: (2019)

A DNA Prime Immuno-Potentiates a Modified Live Vaccine against the Porcine Reproductive and Respiratory Syndrome Virus but Does Not Improve Heterologous Protection
por: Bernelin-Cottet, Cindy, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jgioclo5305ljvqjlgks4ue94i